3 ·Filed Aug 12, 2026

ERAS

Erasca, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001193125-26-346920
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

This is a routine insider onboarding filing with no trading signal. Monitor future Form 4 filings for any open-market purchases or sales by Fuchs, which would provide actionable insider sentiment.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
ERAS ▼ -11.09% at T+20d
NEUTRAL call ✗ call lost -11.09% · α vs SPY -9.34% · entry $17.86 → $15.88
Next anchor: T+60d in 5w
Latest observation: T+34 -50.83% FF3 residual α
Entry anchored
Aug 12, 04:00 PM ET
via 1-min bar
T+1d
+2.91%
call +2.91% · α +3.11%
$18.38
settled 7w ago
T+5d
-4.37%
call -4.37% · α -2.40%
$17.08
settled 6w ago
T+20d
-11.09%
call -11.09% · α -9.34%
$15.88
settled 22d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

Charles S. Fuchs, President of R&D at Erasca, filed a Form 3 initial statement of beneficial ownership, indicating he became a reporting insider. This is a routine administrative filing with no trading activity or financial details disclosed, and carries no material stock-moving implications.

Key Facts

  • Charles S. Fuchs filed a Form 3 initial statement of beneficial ownership on 2026-08-10.
  • Fuchs serves as President, R&D at Erasca, Inc.
  • The filing is a standard SEC requirement for new insiders and contains no trading or financial data.

Financial Impact

No financial impact — filing contains no monetary figures or transaction details.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (17 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001193125-26-346920
Document: 0001193125-26-346920-index.html0001193125-26-346920
Document: 0001193125-26-346920.txt0001193125-26-346920
21 reports for ERAS
Performance horizon
89% Hit rate 8 of 9 directional calls best @ T+60▲ +95.35%Apr 27, 2026
Filters
Rows
Reports for ERAS — sortable, filterable
TypeNow
Aug 24, 2026
5w ago
8-K
BULLISH ★ 5/10
$17.60 $15.55▼ −11.65%▼ −12.96%$14.94 (−15.09%)
Aug 17, 2026
6w ago
144
NEUTRAL ★ 3/10
$18.28 $16.16▼ −11.60%▼ −10.07%$14.94 (−18.24%)
Aug 13, 2026
7w ago
Institutional Cluster
BULLISH ★ 6/10
$17.86 $15.88▼ −11.09%▼ −9.34%$14.94 (−16.32%)
Aug 12, 2026
7w ago
3
NEUTRAL ★ 2/10
$17.86 $15.88▼ −11.09%▼ −9.34%$14.94 (−16.32%)
Aug 11, 2026
7w ago
Press Release
NEUTRAL ★ 5/10
$18.58 $16.03▼ −13.72%▼ −11.83%$14.94 (−19.56%)
Jul 22, 2026
10w ago
Press Release
BEARISH ★ 6/10
$19.51 $18.07▲ +7.38%▲ +10.28%$14.94 (+23.40%)
Jul 14, 2026
11w ago
8-K
MIXED ★ 6/10
$21.26 $18.58▼ −12.61%▼ −14.95%$14.94 (−29.70%)
Jul 14, 2026
11w ago
424B5
MIXED ★ 6/10
$21.26 $18.58▼ −12.61%▼ −14.95%$14.94 (−29.70%)
Jul 14, 2026
11w ago
Press Release
BEARISH ★ 7/10
$19.50 $18.31▲ +6.10%▲ +8.59%$14.94 (+23.36%)
Jul 13, 2026
11w ago
Press Release
BULLISH ★ 7/10
$19.50 $18.31▼ −6.10%▼ −8.59%$14.94 (−23.36%)
Showing 10 of 21

US Market Status

Market Open — Closes in 3h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access